Provided by Tiger Trade Technology Pte. Ltd.

Atara Biotherapeutics

9.02
+0.12001.35%
Post-market: 9.020.00000.00%16:10 EDT
Volume:51.94K
Turnover:468.71K
Market Cap:90.54M
PE:-7.59
High:9.18
Open:8.96
Low:8.80
Close:8.90
52wk High:19.15
52wk Low:3.92
Shares:10.04M
Float Shares:4.73M
Volume Ratio:1.41
T/O Rate:1.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1889
EPS(LYR):2.57
ROE:-2014.86%
ROA:-24.14%
PB:-2.45
PE(LYR):3.51

Loading ...

Aug 09, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 10, 2023

Major Issues Report

Form 8-K - Current report
Jun 06, 2023

Major Issues Report

Form 8-K - Current report
May 12, 2023

Major Issues Report

8-K - Current report
May 08, 2023

Major Issues Report

8-K - Current report
May 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 21, 2023

Correspondence

Form CORRESP - Correspondence
Mar 31, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 08, 2023

Major Issues Report

8-K - Current report
Feb 08, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 18, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 06, 2023

Major Issues Report

8-K - Current report
Dec 20, 2022

Major Issues Report

8-K - Current report